Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab [RoActemra/Actemra];   Drug: adalimumab;   Drug: placebo;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Recruiting - verified July 2011